Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.

<h4>Background</h4>Photodynamic therapy (PDT) uses the combination of photosensitizing drugs and harmless light to cause selective damage to tumor cells. PDT is therefore an option for focal therapy of localized disease or for otherwise unresectable tumors. In addition, there is increasi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robert Kammerer, Alexander Buchner, Patrick Palluch, Thomas Pongratz, Konstantin Oboukhovskij, Wolfgang Beyer, Ann Johansson, Herbert Stepp, Reinhold Baumgartner, Wolfgang Zimmermann
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ac8ba1f4027a4e32aefeace7d07ee43e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ac8ba1f4027a4e32aefeace7d07ee43e
record_format dspace
spelling oai:doaj.org-article:ac8ba1f4027a4e32aefeace7d07ee43e2021-11-18T06:50:51ZInduction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.1932-620310.1371/journal.pone.0021834https://doaj.org/article/ac8ba1f4027a4e32aefeace7d07ee43e2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21738796/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Photodynamic therapy (PDT) uses the combination of photosensitizing drugs and harmless light to cause selective damage to tumor cells. PDT is therefore an option for focal therapy of localized disease or for otherwise unresectable tumors. In addition, there is increasing evidence that PDT can induce systemic anti-tumor immunity, supporting control of tumor cells, which were not eliminated by the primary treatment. However, the effect of non-lethal PDT on the behavior and malignant potential of tumor cells surviving PDT is molecularly not well defined.<h4>Methodology/principal findings</h4>Here we have evaluated changes in the transcriptome of human glioblastoma (U87, U373) and human (PC-3, DU145) and murine prostate cancer cells (TRAMP-C1, TRAMP-C2) after non-lethal PDT in vitro and in vivo using oligonucleotide microarray analyses. We found that the overall response was similar between the different cell lines and photosensitizers both in vitro and in vivo. The most prominently upregulated genes encoded proteins that belong to pathways activated by cellular stress or are involved in cell cycle arrest. This response was similar to the rescue response of tumor cells following high-dose PDT. In contrast, tumor cells dealing with non-lethal PDT were found to significantly upregulate a number of immune genes, which included the chemokine genes CXCL2, CXCL3 and IL8/CXCL8 as well as the genes for IL6 and its receptor IL6R, which can stimulate proinflammatory reactions, while IL6 and IL6R can also enhance tumor growth.<h4>Conclusions</h4>Our results indicate that PDT can support anti-tumor immune responses and is, therefore, a rational therapy even if tumor cells cannot be completely eliminated by primary phototoxic mechanisms alone. However, non-lethal PDT can also stimulate tumor growth-promoting autocrine loops, as seen by the upregulation of IL6 and its receptor. Thus the efficacy of PDT to treat tumors may be improved by controlling unwanted and potentially deleterious growth-stimulatory pathways.Robert KammererAlexander BuchnerPatrick PalluchThomas PongratzKonstantin OboukhovskijWolfgang BeyerAnn JohanssonHerbert SteppReinhold BaumgartnerWolfgang ZimmermannPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 6, p e21834 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Robert Kammerer
Alexander Buchner
Patrick Palluch
Thomas Pongratz
Konstantin Oboukhovskij
Wolfgang Beyer
Ann Johansson
Herbert Stepp
Reinhold Baumgartner
Wolfgang Zimmermann
Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
description <h4>Background</h4>Photodynamic therapy (PDT) uses the combination of photosensitizing drugs and harmless light to cause selective damage to tumor cells. PDT is therefore an option for focal therapy of localized disease or for otherwise unresectable tumors. In addition, there is increasing evidence that PDT can induce systemic anti-tumor immunity, supporting control of tumor cells, which were not eliminated by the primary treatment. However, the effect of non-lethal PDT on the behavior and malignant potential of tumor cells surviving PDT is molecularly not well defined.<h4>Methodology/principal findings</h4>Here we have evaluated changes in the transcriptome of human glioblastoma (U87, U373) and human (PC-3, DU145) and murine prostate cancer cells (TRAMP-C1, TRAMP-C2) after non-lethal PDT in vitro and in vivo using oligonucleotide microarray analyses. We found that the overall response was similar between the different cell lines and photosensitizers both in vitro and in vivo. The most prominently upregulated genes encoded proteins that belong to pathways activated by cellular stress or are involved in cell cycle arrest. This response was similar to the rescue response of tumor cells following high-dose PDT. In contrast, tumor cells dealing with non-lethal PDT were found to significantly upregulate a number of immune genes, which included the chemokine genes CXCL2, CXCL3 and IL8/CXCL8 as well as the genes for IL6 and its receptor IL6R, which can stimulate proinflammatory reactions, while IL6 and IL6R can also enhance tumor growth.<h4>Conclusions</h4>Our results indicate that PDT can support anti-tumor immune responses and is, therefore, a rational therapy even if tumor cells cannot be completely eliminated by primary phototoxic mechanisms alone. However, non-lethal PDT can also stimulate tumor growth-promoting autocrine loops, as seen by the upregulation of IL6 and its receptor. Thus the efficacy of PDT to treat tumors may be improved by controlling unwanted and potentially deleterious growth-stimulatory pathways.
format article
author Robert Kammerer
Alexander Buchner
Patrick Palluch
Thomas Pongratz
Konstantin Oboukhovskij
Wolfgang Beyer
Ann Johansson
Herbert Stepp
Reinhold Baumgartner
Wolfgang Zimmermann
author_facet Robert Kammerer
Alexander Buchner
Patrick Palluch
Thomas Pongratz
Konstantin Oboukhovskij
Wolfgang Beyer
Ann Johansson
Herbert Stepp
Reinhold Baumgartner
Wolfgang Zimmermann
author_sort Robert Kammerer
title Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
title_short Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
title_full Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
title_fullStr Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
title_full_unstemmed Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
title_sort induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/ac8ba1f4027a4e32aefeace7d07ee43e
work_keys_str_mv AT robertkammerer inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT alexanderbuchner inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT patrickpalluch inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT thomaspongratz inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT konstantinoboukhovskij inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT wolfgangbeyer inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT annjohansson inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT herbertstepp inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT reinholdbaumgartner inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
AT wolfgangzimmermann inductionofimmunemediatorsingliomaandprostatecancercellsbynonlethalphotodynamictherapy
_version_ 1718424313466454016